Top 4 Stocks In The Drugs-Generic Industry With The Highest Cash

Below are the top drugs-generic stocks on the NYSE and the NASDAQ in terms of cash.

Salix Pharmaceuticals (NASDAQ: SLXP) had $817.98 million in total cash and $875.74 million in total debt for the latest quarter.

Mylan (NASDAQ: MYL) had $360.07 million in total cash for the latest quarter. However, Mylan had $6.22 billion in total debt for the same period.

Hi-Tech Pharmacal Co (NASDAQ: HITK) had $108.28 million in total cash and $1.15 million in total debt for the latest quarter.

Akorn (NASDAQ: AKRX) had $58.41 million in total cash and $106.66 million in total debt for the latest quarter.